Pangenomic - PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports and Closing of its Non-Brokered Private Placement Offering
Summary
Finally, the Company also announced that it has retained Pulse Investor Relations Services Inc. ("PulseIR") to provide digital marketing services for investor relations.The NARA MIND Report will provide users with unique tailored mental health insights that cover their genetic disposition, micronutrient sensitivity, natural supplement susceptibility profile and metabolic diet report.Nara generates the personalized DNA Report by performing an analysis of a users unique DNA sequences that are specifically connected to key genes related to mental health. If the closing price of the Shares on the Canadian Securities Exchange is greater than or equal to $0.60 for 10 consecutive trading days, the Company has the right to accelerate the expiration date of the Warrants. PulseIR participated in the Offering by subscribing for 840,000 Units at an aggregate price of $126,000.PulseIR is a digital marketing and advisory services firm based in Vancouver, BC, that specializes in providing its mobile-first, social-centric, community platform for investor relations. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "would", "project", "should", "believe" and similar expressions are intended to identify forward looking statements. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in PanGenomics disclosure documents which can be found under PanGenomics profile on www.sedar.com.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.For further information please contact: